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doi:10.1016/j.ejvs.2010.03.019Abstract Objectives: This article describes the long-term outcome of surgical treatment in
children with renovascular hypertension (RVH) over a 40-year period.
Design: Retrospective study.
Materials and methods: Twenty-five consecutive patients, aged 5e21 years, underwent renal
artery (RA) repair from 1967 to 1995. The disease consisted of fibromuscular dysplasia in
17 patients, Takayasu’s arteritis in 7 and neurofibromatosis type 1 in one patient.
Results: Twenty-nine RAs were repaired. Primary procedures included aortorenal bypass (ARB)
with prosthesis in 10 RAs, autologous vein in five or internal iliac artery in four as conduits,
direct reimplantation (DR) in four and nephrectomy in two RAs. Immediate graft failure
occurred in three patients despite no peri-operative deaths. After a mean follow-up of 24.4
years, seven patients required secondary nephrectomy. Autologous ARB or DR showed better
RA patency and fewer chances for secondary nephrectomy than prosthetic ARB. Hypertension
was cured or improved in 21 patients. The overall cumulative survival rate at 20 years was 84%.
All five deaths, observed a mean of 12.6 years after the initial operation, were attributed to
cardiovascular events.
Conclusions: Surgical treatment, especially autologous ARB or DR, seems to provide durable
results for paediatric RVH. Long-term observation and control of hypertension is mandatory.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.The overall incidence of hypertension is estimated to be
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732 H. Kimura et al.most common cause of surgically correctable hypertension
in the paediatric population is renovascular disease.2 Renal
ischaemia can be caused by renal artery stenosis (RAS) or
narrowing and coarctation of the aorta or both. A hetero-
geneous group of arterial diseases is responsible for these
lesions.3 The most frequent cause is fibromuscular dysplasia
(FMD). Takayasu’s arteritis (TA) is another important cause
of paediatric renovascular hypertension (RVH), especially in
Asian countries.4
In spite of a heterogeneous group of renal artery (RA)
lesions, there is a common mechanism whereby renal
ischaemia produces persistent elevation of blood pressure.
Reduction in RA blood pressure caused by severe RAS leads
to hypotension of the kidney and activates the
renineangiotensin system. Excessive release of renin and
production of angiotensin II are responsible for systemic
hypertension.5
Management of RVH consists of proper control of severe
hypertension and preservation of the renal parenchyma. RA
repairs, whether surgical or endovascular, are essential
when hypertension is resistant to anti-hypertensive (AH)
medication. This retrospective study examined the efficacy
of RA repair in children and adolescents by reviewing the
long-term outcomes of 25 consecutive patients in a single
institution.Patients and methods
We reviewed clinical records of patients, 21 years or
younger, who were referred to The Second Department of
Surgery at The University of Tokyo Hospital for consider-
ation of surgical treatment of RVH. The underlying causes
of RA lesions were established by clinical and angio-
graphical evaluation and confirmed by surgical and path-
ological findings. Diagnosis of TA was confirmed by
characteristic clinical and radiological findings6 that are
compatible with the criteria outlined by the American
College of Rheumatology.7 Neurofibromatosis type 1 (NF-1)
was diagnosed by multiple cafe´-au-lait spots and the
presence of a first-degree relative with NF-1, criteria for
which were established by the National Institutes of
Health.8 FMD was defined as an idiopathic, segmental, non-
inflammatory and non-atherosclerotic disease of the
musculature of small- and medium-sized arterial walls
including the renal and carotid arteries.9 The diagnosis was
made by radiological and pathological findings, if
available.
Patient blood pressure and mortality data were obtained
from clinical records, and supplemented with information
obtained via telephone interviews with the patients or their
physicians. Data obtained during the initial clinical and the
final follow-up visit were used for the analysis. Hyperten-
sive retinopathy was positive if retinal findings were clas-
sified into KeitheWagener Grade I or more severe. Plasma
renin activity (PRA) was abnormal if it exceeded 2.0 ng mle1
he1 and ipsilateral elevation of PRA was defined as affected
side/unaffected side >1.5 or affected side/infrarenal
inferior vena cava >1.5. Erythrocyte sedimentation rate
(ESR) was evaluated before steroid therapy. Aortography
was performed in all patients and selective RA angiography
was added to the tests after 1975. RA lesions were analysedbased on angiographical findings and were categorised as
follows: ost e lesions confined to the ostium of the main
trunk; main e lesions confined to the main trunk but not
involving the ostium; and seg e lesions of a segmental
artery.
Renal artery repair was considered when (1) the diag-
nosis of RVH was made and other causes of hypertension
were ruled out and (2) AH medication failed to control
blood pressure.
The RA repair patency was assessed clinically by angi-
ography, duplex scan or both. The RA repair outcome was
evaluated based on blood pressure and the requirement for
AH medication. Hypertension was defined as average
systolic and/or diastolic blood pressure greater than or
equal to the 95th percentile for sex, age and height.10
Blood pressure response was defined as follows:
 Cured e normalisation of blood pressure to below the
expected 95th percentile without requiring AH
medication;
 Improved e normalisation of blood pressure while on
the same drug therapy or decrease in diastolic pressure
by more than 15% compared with the preoperative
level; or
 Failed e persistent hypertension despite AH therapy
with less than a 15% decrease in diastolic pressure
compared with the preoperative level.
Results
Patients’ background
Patients consisted of 17 females and eight males, whose
age at treatment was 17.2 years (range, 5e21 years). FMD
was present in 17, TA in seven and NF-1 in one patient.
The distribution of patients’ ages and aetiologies of RVH
are shown in Table 1 and Fig. 1. In principle, all patients
had been treated medically for hypertension before
admission to our hospital. However, AH medication was
abandoned due to its ineffectiveness for blood pressure
control in two patients with FMD, and no information
regarding medical therapy before admission was available
for two patients with FMD. All FMD and two TA patients
showed ESR <20 mm h1, but the remaining five TA
patients showed elevated ESR (mean  SEM: 80  15 mm
h1). These patients were administered a steroid pre-
operatively for 31 (range, 3e108) months, during which
time ESR levels declined to 12  4 mm h1 at the time of
RA repair. One patient with FMD had undergone
nephrectomy and another with FMD had recurrent RAS
after percutaneous transluminal renal angioplasty (PTRA).
Severe hypertension was present in all patients pre-
operatively. The mean preoperative blood pressure was
198  5/111  3 mmHg at the time of diagnosis and 182 
6/104  4 mmHg on admission with a mean of 2.0 drugs
(range, 0e4). Fourteen patients had symptoms or sequelae
of severe hypertension including headache, nausea, palpi-
tations and dyspnoea. One patient had seizures. A vascular
bruit in the abdomen was audible in 14 patients and
hypertensive retinopathy was found in 12. PRA was
Table 1 Patient characteristics.
Etiology Number Sex (M/F) Age range (Mean) Preoperative medication
AH agents Steroid None
FMD 17 7/10 5e21 (18) 12 0 5
TA 7 1/6 5e21 (16) 7 5 0
NF-1 1 0/1 12 1 0 0
FMD: fibromuscular dysplasia, TA: Takayasu’s arteritis, NF-1: neurofibromatosis type 1, AH: anti-hypertensive.
Renovascular Hypertension in Children and Adolescents 733estimated in the peripheral blood of all patients and was
elevated in 16. Ipsilateral elevation of renin activity was
seen in 10 out of 19 patients whose central vein blood
was sampled. An abnormal renogram pattern was seen in
21 out of 24 patients who underwent renography. Stimula-
tion of renin secretion by administration of captopril,
apresoline or frosemide, or by no salt intake was conducted
in 12 patients. All PRA and renography data were obtained
under AH therapy and with renin stimulation, if present.
Preoperative angiography showed bilateral RA lesions in
six, aneurysmal change associated with RA stenosis in five
and an aberrant polar RA in seven patients. Locations of the
RA lesions are shown in Table 2. All RA lesions in TA were
present within the main RA, whereas 32% of those in FMD
were located in the segmental arteries.
No patient was affected by aortic coarctation or hypo-
plasia. Two FMD patients had other vascular lesions e one
with stenosis of the subclavian artery and multiple stenoses
of pulmonary arteries and the other with moyamoya
disease. Four TA and one NF-1 patient exhibited concomi-
tant stenotic lesions of the aortic branches including the
innominate (n Z 1), subclavian (n Z 2), common carotid
(n Z 1), celiac (n Z 2) and superior mesenteric arteries
(n Z 3). No patient presented with abdominal angina or
cerebral ischaemia.
In all cases, RVH was diagnosed based on the presence
of persistent hypertension and RAS on arteriography.
Arteriography was the only modality for making the diag-
nosis in two FMD cases, where plasma renin activity and
renogram were normal when renin secretion was
stimulated.Figure 1 Age distribution of patients. FMD: fibromuscular
dysplasia; TA: Takayasu’s arteritis; NF-1: neurofibromatosis
type 1.RA repair and follow-up
Overall, 29 RAs were repaired in 25 patients (Table 3). Of six
bilateral RA lesions, four patients required single-stage
reconstruction of the bilateral RAs. The remaining two
required single repair, because one patient had already
undergone nephrectomy on the other side and the other
had only mild stenosis of the contralateral RA. Aorto renal
bypasses (ARBs) were performed with prosthetic grafts for
10 RAs and autologous grafts including the saphenous vein
and internal iliac artery (IIA) for nine. Use of the IIA was
preferred for younger patients but one patient aged
12 years underwent RA bypass with the saphenous vein
because the IIA was used for contralateral RA reconstruc-
tion. Direct anastomosis of the RA to the aorta after
resection of its stenotic lesion (direct reimplantation; DR)
was performed for four RAs. Prosthetic bypasses were
performed until 1974, while autologous bypass and DR have
been performed since 1975. Vein patch angioplasty was
performed in two RAs, and PTRA and open operative dila-
tation were performed in each. Branch reconstruction was
required for six patients with FMD or NF-1 and one with TA
whose lower segmental artery required patch angioplasty
due to a technical problem. All surgical procedures of the
affected kidney were performed in situ without using cold
saline perfusion. Primary nephrectomy was performed in
two patients for whom revascularisation was impossible No
patient required revascularisation of the concomitant
stenosis of other aortic branches. Pathological RA exami-
nation was performed in 18 patients (11 with FMD and seven
with TA), and all microscopical findings were compatible
with the clinical diagnosis.
Short-term outcome (within 30 days after RA
repair)
There was no death related to RA repair. An immediate
occlusion of reconstructed RA occurred post-operatively
in three patients including two with prosthetic ARB and
one with patch angioplasty, all of whom underwent
branch reconstruction. Another patient with FMD suffered
sustained hypertension due to post-operative partial renal
infarction despite a patent prosthetic graft. Short-term
RA patency was 80% for prosthetic ARB versus 100% for
autologous ARB or DR. No patient experienced deteriora-
tion of renal function post-operatively. The mean post-
operative blood pressure at discharge was 139  4/80  3
mmHg. Hypertension was cured or improved in 22
patients (88%) including one with FMD who underwent
unplanned nephrectomy after immediate graft failure.
Table 2 Vascular lesions.
Etiology Number of cases Number of affected RA Location of RAS RAA Vascular lesions other than RA
Ost Main Main þ Seg Seg
FMD 17 19 4 9 2 4 3 2a
TA 7 11 8 3 0 0 1 4b
NF-1 1 1 0 0 1 0 1 1c
FMD: fibromuscular dysplasia, TA: Takayasu’s arteritis, NF-1: neurofibromatosis type 1.
RA: renal artery, RAS: renal artery stenosis, RAA: renal artery aneurysm.
Ost: ostial, Main: main renal artery, Seg: segmental renal artery.
a One with subclavian artery (SCA) stenosis þ pulmonary artery multiple stenosis and the other with moyamoya disease.
b One with occlusion of innominate artery þ common carotid artery þ SCA, one with stenosis of SCA þ superior mesenteric artery
(SMA), one with stenosis of celiac artery (CA) and occlusion of SMA, one with occlusion of SMA.
c Associated with occlusion of CA.
734 H. Kimura et al.Control of post-operative blood pressure failed due to
graft occlusion in two patients and renal infarction in the
other (Table 4).
Long-term outcome (more than 1 month after RA
repair)
The follow-up period for 25 patients with RVH ranged
from 5 to 39 years (mean  SEM, 24.4  2.3 years).
Although no patient showed vein graft dilatation, four
had evident occlusion of the reconstructed RA during the
follow-up period. Two patients with TA showed prosthetic
graft occlusion in 2 and 8 months after ARB, while
another TA patient revealed occlusion of a vein graft
89 months post-operatively. The remaining patient with
FMD whose RA was occluded at an unknown time point
had severe hypertension and renal failure 12 years after
surgery.
Two patients with FMD and four with TA underwent total
or partial nephrectomy in the follow-up period. Indications
for nephrectomy were recurrent severe hypertension after
failure of RA reconstruction in four patients (2 and 8 months
after prosthetic ARB in each patient with TA, 8 months after
patch angioplasty in a patient with FMD and 89 months after
autologous ARB in a patient with TA) and persistentTable 3 Initial treatment for RAS.
Etiology FMD TA NF-1
Number of treated RA 18 10 1
Arterial bypass
Prosthesisa 5 5 0
Veinb 4 1 0
IIAb 1 2 1
Reimplantationb 3 1 0
Patch angioplasty 2 0 0
Angioplasty 2 0 0
Primary nephrectomy 1 1 0
FMD: fibromuscular dysplasia, TA: Takayasu’s arteritis, NF-1:
neurofibromatosis type 1, RA: renal artery, IIA: internal iliac
artery.
a Cases before Jan 1975.
b Cases after Jan 1975.hypertension due to partial renal infarction in a patient
with FMD (7 months after prosthetic ARB). The remaining
patient in whom the prosthetic graft had immediately
occluded developed an anastomotic aneurysm between the
aorta and the graft, and successfully underwent aneur-
ysmectomy as well as total nephrectomy 22 years after the
initial RA repair. Therefore, 5 out of 10 patients required
nephrectomy in the follow-up period after prosthetic ARB
while only 1 out of 13 patients required the same after
autologous ARB or DR.
Hypertension was cured in 15 (60%), improved in six
(24%) and unchanged in four (16%) patients (Table 5). The
reasons for poor blood pressure control were failure of the
initial RA repair without further surgical treatment for two
patients with FMD and one with TA; the reason was
unknown for the remaining patient with TA who underwent
primary nephrectomy. Thus, blood pressure control was
achieved in 15 patients with FMD, five with TA and one
with NF-1. These results show no difference in hypertension
outcome either between patients with FMD and TA
(Table 5), or between patients after prosthetic ARB and
those after autologous ARB or DR.
Five deaths occurred at the mean age of 31.8  5.4
years during a mean follow-up period of 12.6  2.8 years
(Table 5). All deaths were attributed to cardiovascular
events including heart failure in three, myocardial
infarction in one, and subarachnoid haemorrhage in one
patient. One patient with TA and two with FMD suffered
recurrent hypertension after RA reconstruction failure and
died of heart failure 5, 9 and 17 years after surgery at age
25, 28 and 36, respectively. The remaining one patient
with FMD and one with TA underwent primary nephrec-
tomy at age 20 and 18 years respectively, and died of
myocardial infarction and subarachnoid haemorrhage
12 and 20 years, respectively, after the initial surgery. This
patient with TA had recurrent hypertension and the other
with FMD had well-controlled hypertension. Neither
patient had showed RA lesions on the contralateral side at
the time of surgery. The cumulative survival rate for all
patients was 95%, 90% and 84% at 5, 10 and 20 years,
respectively. There was no difference in survival rates
between ARB with prosthesis and ARB with autograft/DR
(data not shown). In addition, presence of FMD and TA as
causes of RAS did not influence the survival rates in our
series (Fig. 2).
Table 4 Short-term outcome.
Etiology Procedures
FMD TA NF-1 Prosthetic ARB Autologous ARB/DR Miscellaneous
Number of cases 17 7 1 9 (10) 11 (13)a 6 (6)a
Graft/patch failure 2 1 0 2 0 1
Secondary nephrectomy 1 0 0 1 0 0
Short-term outcome
Cured 10 5 1 5 9 2
Improved 5 1 0 2 2a 3a
Failed 2 1 0 2 0 1
FMD: fibromuscular dysplasia, TA: Takayasu’s arteritis, NF-1: neurofibromatosis type 1, ARB: aortorenal bypass, DR: direct
reimplantation.
The number of repaired RA is shown in parentheses.
a Both numbers include a patient with FMD who underwent autologous ARB for the right and angioplasty for the left RA.
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This article reviewed the surgical treatment for RVH in
children and adolescents with heterogeneous types of RA
lesions. Similar to other papers describing paediatric
RVH11e17, our study revealed that FMD was the most
common cause of RAS. A pathological classification of renal
artery FMD was is based on a dominant arterial wall layer
that shows dysplasia or hyperplasia, and lesions are classi-
fied as three main types: intimal, medial and perimedial.18
Medial and perimedial FMD account for nearly 95% of all
FMD stenosis cases.19
TA, characterised by non-specific inflammation of the
aorta and its branches, is a major cause of RVH in the young
population, especially in Asian countries.4,17 Thus, unlike
Western countries, a high incidence of TA was seen in our
series. Most of our patients with TA had an ostial RA lesion,
in contrast to FMD, in which not only the main artery but its
segments are often affected.
NF-1 is the most common cause of genetically deter-
mined RA disorders. Vascular lesions associated with NF-1Table 5 Long-term outcome.
Etiology
FMD TA NF-1
Number of cases 17 7 1
Graft/patch failure 1 3 0
Secondary nephrectomy 2 4 0
Long-term outcome
Cured 12 3 0
Improved 3 2 1
Failed 2 2 0
Death 3 2 0
Causes of death
Congestive heart failure 2 1 0
Myocardial infarction 1 0 0
Subarachnoid haemorrhage 0 1 0
FMD: fibromuscular dysplasia, TA: Takayasu’s arteritis, NF-1: neurofi
tation.
The number of repaired RA is shown in parentheses.
a Both numbers include a patient with FMD who underwent autologous
failure.usually consist of stenosis of the aortic branches, espe-
cially the RA, SMA and CA, and coarctation of the
abdominal aorta.20
The diagnostic pathway of RVH in children was shown in
a recent review.21 Children showing signs of RVH such as
severe hypertension, abdominal bruits, end-organ damages
and raised peripheral PRA, as well as those who are at
a high risk of vascular disease, should undergo investigation
including angiography and central vein renin sampling. The
RVH treatment pathway21 shows that children with blood
pressure that is not well controlled with more than two
drugs should receive RA revascularisation, which aims to
control blood pressure and preserve renal function. In our
and other paediatric cases,11,13e16 RA revascularisation had
favourable clinical outcomes. However, in a recent rando-
mised trial,22 RA revascularisation for atherosclerotic RAS
had no or little benefit for renal function, blood pressure
control, morbidity and mortality. This discrepancy may
indicate that RAS in young patients shows rather isolated
lesions and plays a major role in blood pressure control and
renal function, compared with RAS in atherosclerosis.Procedures
Prosthetic ARB Autologous ARB/DR Miscellaneous
9 (10) 11 (13)a 6 (6)a
2 1 1
4 1 1
4 9 2
4 1 1
1 1a 3a
1 1a 4a
1 2a 2a
0 0 1
0 0 1
bromatosis type 1, ARB: aortorenal bypass, DR: direct reimplan-
ARB for the right and angioplasty for the left RA, and died of heart
Figure 2 Cumulative survival rates. The solid line corre-
sponds to the overall patient survival rate. The long dotted and
short dotted lines indicate the survival rates of cases with FMD
and TA, respectively, showing no significant difference. The
upper and lower lanes at the bottom indicate the numbers of
cases at risk with FMD and TA, respectively.
736 H. Kimura et al.Therefore, aggressive treatment of RAS should be advo-
cated for paediatric RVH.
We performed prosthetic RA revascularisation prior to
1975, but changed to RA bypass with autologous RA
bypasses or DR thereafter. This shift was justified because
autologous ARB or DR improved RA patency, at least within
1 year after surgery, and lessened the chance for secondary
nephrectomy. Use of IIA grafts as a conduit for autologous
bypasses is preferred, because its patency is good and graft
dilatation is rare. For ostial lesions, DR is also a durable
alternative with little chance of anastomotic complica-
tions.14,23 In contrast to autologous grafting, use of pros-
thesis might lead to failure of the anastomosis or graft
occlusion since the prosthesis does not change in size along
with normal vessel growth and the amount of RA blood flow
may be too small for long-term patency of small-calibre
prosthetic grafts. In spite of better patency, autologous
ARB or DR showed no difference in long-term blood pres-
sure control compared with prosthetic ARB. This may be
explained by the fact that secondary nephrectomy
improved hypertension control in five patients whose
prosthetic grafting failed. Thus, nephrectomy can be an
acceptable treatment option after RA revascularisation
failure. Immediate failure of RA repair was seen only in
patients undergoing RA branch reconstruction withTable 6 Reports on hypertension outcomes after surgical treatm
Location N Years Hyperte
% Cured
Ann Harbor, Mich15 97 1963e2006 70
Clichy, France14 78 1975e98 87
Cleveland, Ohio16 56 1955e88 66
Nashville, Tenn &
Philadelphia, Penn11
53 NS 70
Winston-Salem, NC13 25 1987e2004 36
Tokyo, Japan 25 1967e95 60
N: number of patients, F/U: follow-up, NS: not stated.prosthesis or vein patch angioplasty, suggesting that not
only the kind of conduit but also the technique may be
critical for graft patency.
Recently, there have been a growing number of PTRA
experiences for the treatment of paediatric RAS.17 Etiology
and the type of lesion are particularly important when
PTRA is considered. As lesions in FMD sometimes affect RA
branches, the surgical procedures are often complicated,
so PTRA may be a better solution. Primary patency after
PTRA is more than 80% at 10 years, and PTRA can be
repeated if re-stenosis occurs.24 The efficacy of PTRA in
TA25 and NF-126 patients is more disappointing and its
performance is still controversial. The main reason for only
one patient undergoing PTRA in our series was the high
prevalence of surgical procedures and the low availability
of PTRA during or prior to the 1990s. Recent advances in
endovascular techniques enable many cases with RAS to be
treated with PTRA, but it should be noted that surgical
treatment is still indicated, especially for lesions such as
extensive RA involvement, aneurysms and atrophic kidney.
Table 6 lists recent reports on hypertension outcomes
after surgical treatment for RVH in 25 or more children and
adolescents. All of these reports demonstrated that FMD
was a prominent etiology of RA lesions, and more than 85%
of the surgical procedures were RA reconstructions that
included bypass or DR. Long-term hypertension outcomes
were similar among these reports, and approximately 90%
or more of patients benefited from surgical treatment. Only
our study has a mean follow-up period of 24.4 years, while
the others showed a mean of less than 10 years. It is
preferable for paediatric patients to be followed up for
more than a decade when the long-term outcome of RA
repair is evaluated.
We have tried to examine the difference in blood pressure
response between patients with FMD and TA despite the
small study population. Very few articles have described this
difference.4 Failure rates of RA repair depend not on the
etiology of RA lesions but on the procedure of RA repair, as
shown by inferior patency of prosthetic grafting, at least
those within a year after surgery. Furthermore, RA repair
including secondary nephrectomy benefited 15 out of
17 patients with FMD and five out of seven with TA during the
follow-up period, showing no significant difference in blood
pressure responses between patients with FMD and TA in the
long-term period.
Causes of death after surgical treatment of RVH were
not discussed in either report shown in Table 6. Fiveent of renovascular hypertension in children and adolescents.
nsion outcome F/U year range (Mean)
% Improved % Failed
27 3 0.3e42 (4.2)
10 4 1e14 (9.4)
23 11 NS (7.6)
26 4 0.8e16 (NS)
56 8 0.1e11.7 (3.9)
28 12 5e39 (24.4)
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years in our series, and all deaths were cardiovascular-
related. Four out of five patients who died suffered
from hypertension, and this condition might have been
related to the fatal events. As shown in Fig. 2, there is no
difference in survival rates between patients with FMD
and TA. It is interesting to note that a patient with TA
who underwent primary nephrectomy developed severe
hypertension, probably due to stenosis of the contralat-
eral RA, which was patent at the time of the initial
surgery. This indicates that long-term close follow-up is
essential in terms of proper hypertension control and
scrutiny of RA patency of both the affected and the
contralateral side.
In conclusion, we have examined RA repair in 25
paediatric and adolescent cases with RVH whose aetiol-
ogies included FMD in 68% and TA in 28%. We have shifted
our strategy of RA revascularisation from prosthetic ARB
to autologous ARB or DR. This has led to the improvement
of RA patency and a decrease in the number of cases
requiring secondary nephrectomy. Secondary nephrec-
tomy might be an alternative for patients who lack
hypertension control due to graft failure. Because all
deaths were attributed to cardiovascular events, long-
term follow-up is mandatory especially to ensure hyper-
tension control.
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